{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T12:57:00Z","timestamp":1773233820238,"version":"3.50.1"},"reference-count":14,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T00:00:00Z","timestamp":1767657600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Aust J Dermatology"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Bullous pemphigoid (BP) is a common autoimmune blistering disease associated with medications, particularly dipeptidyl peptidase\u20104 inhibitors such as vildagliptin, funded in New Zealand since 2018. We conducted a retrospective single\u2010centre study of histologically confirmed BP cases between 2018 and 2023. Of 49 patients identified, 15 (30.6%) had vildagliptin\u2010induced BP. M\u0101ori patients were over\u2010represented in this subgroup. The mean time to BP onset after vildagliptin initiation was 388\u2009days. Non\u2010vildagliptin BP was more likely to require systemic immunosuppression. Vildagliptin\u2010induced BP represents a common and under\u2010recognised clinical entity in New Zealand.<\/jats:p>","DOI":"10.1111\/ajd.70039","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:13:20Z","timestamp":1767770000000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vildagliptin\u2010Induced Bullous Pemphigoid: A Retrospective Cohort Study"],"prefix":"10.1111","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4651-9927","authenticated-orcid":false,"given":"Karen","family":"Koch","sequence":"first","affiliation":[{"name":"Department of Dermatology Waikato Hospital  Hamilton Waikato New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Breana","family":"Lim","sequence":"additional","affiliation":[{"name":"Medical School University of Auckland  Auckland Auckland New Zealand"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2026,1,6]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1177\/1203475420972349"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13822"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.12.038"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-0409"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2018.01.027"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1159\/000075040"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/8832643"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.06.032"},{"issue":"1537","key":"e_1_2_11_10_1","first-page":"95","article-title":"Vildagliptin\u2010Induced Bullous Pemphigoid","volume":"134","author":"Zhang A. Y.","year":"2021","journal-title":"New Zealand Medical Journal"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.16970"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2020.108546"},{"issue":"1548","key":"e_1_2_11_13_1","first-page":"77","article-title":"Variation in Open Access Vildagliptin Use in Waikato Patients With Type 2 Diabetes","volume":"135","author":"Chepulis L.","year":"2022","journal-title":"New Zealand Medical Journal"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.adengl.2020.03.011"},{"key":"e_1_2_11_15_1","unstructured":"Government NZ \u201cCensus Statistics Waikato Region 2018 [New Zealand Census Statistics Online] \u201d(2018) https:\/\/www.stats.govt.nz\/tools\/2018\u2010census\u2010place\u2010summaries\/waikato\u2010region."}],"container-title":["Australasian Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.70039","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ajd.70039","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ajd.70039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T16:45:27Z","timestamp":1773161127000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajd.70039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,6]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["10.1111\/ajd.70039"],"URL":"https:\/\/doi.org\/10.1111\/ajd.70039","archive":["Portico"],"relation":{},"ISSN":["0004-8380","1440-0960"],"issn-type":[{"value":"0004-8380","type":"print"},{"value":"1440-0960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,6]]},"assertion":[{"value":"2024-10-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-12-03","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}